High-dose biotin may down-regulate hepatic expression of acute phase reactants by mimicking the physiological role of nitric oxide

Medical Hypotheses

Volumn 61, Issue 4, 2003, Pages 417-418

  McCarty, M F ^a  

^a Pantox Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BIOTIN; CYCLIC GMP; GUANYLATE CYCLASE; INTERLEUKIN 6; NITRIC OXIDE; STAT3 PROTEIN;

DOWN REGULATION; DRUG MEGADOSE; DRUG SCREENING; HUMAN; LIVER; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY;

EID: 0345166839     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00239-6     Document Type: Article

References (20)

1. Villavicencio R. T., Liu S., Kibbe M. R. et al. Induced nitric oxide inhibits IL-6-induced stat3 activation and type II acute phase mRNA expression. Shock 2000; 13: 441-445.
2. Heinrich P. C., Horn F., Graeve L. et al. Interleukin-6 and related cytokines: effect on the acute phase reaction. Z Ernahrungswiss 1998; 37(suppl. 1): 43-49.
3. Bingisser R. M., Tilbrook P. A., Holt P. G., Kees U. R. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 1998; 160: 5729-5734.
4. Vesely D. L. Biotin enhances guanylate cyclase activity. Science 1982; 216: 1329-1330.
5. Spence J. T., Koudelka A. P. Effects of biotin upon the intracellular level of cGMP and the activity of glucokinase in cultured rat hepatocytes. J Biol Chem 1984; 259: 6393-6396.
6. Dakshinamurti K., Cheah-Tan C. Biotin-mediated synthesis of hepatic glucokinase in the rat. Arch Biochem Biophys 1968; 127: 17-21.
7. Chauhan J., Dakshinamurti K. Transcriptional regulation of the glucokinase gene by biotin in starved rats. J Biol Chem 1991; 266: 10035-10038.
8. Zhang H., Osada K., Sone H., Furukawa Y. Biotin administration improves the impaired glucose tolerance of streptozotocin-induced diabetic Wistar rats. J Nutr Sci Vitaminol (Tokyo) 1997; 43: 271-280.
9. Maebashi M., Makino Y., Furukawa Y. et al. Therapeutic evaluation of the effect of biotin on hyperglycemia in patients with non-insulin-dependent diabetes mellitus. J Clin Biochem Nutr 1993; 14: 211-218.
10. Coggeshall J. C., Heggers J. P., Robson M. C., Baker H. Biotin status and plasma glucose in diabetics. Ann N Y Acad Sci 1985; 447: 387-392.
11. Spence J. T., Merrill M. J., Pilot H. C. Role of insulin, glucose, and cyclic GMP in the regulation of glucokinase in cultured hepatocytes. J Biol Chem 1981; 256: 1598-1603.
12. McCarty M. F. High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes. Med Hypotheses 1999; 52: 401-406.
13. Koutsikos D., Agroyannis B., Tzanatos-Exarchou H. Biotin for diabetic peripheral neuropathy. Biomed Pharmacother 1990; 44: 511-514.
14. Simpson L. O. Altered blood rheology in the pathogenesis of diabetic and other neuropathies. Muscle Nerve 1988; 11: 725-744.
15. Young M. J., Bennett J. L., Liderth S. A., Veves A., Boulton A. J., Douglas J. T. Rheological and microvascular parameters in diabetic peripheral neuropathy. Clin Sci (Colch) 1996; 90: 183-187.
16. McCarty M. F. Favorable impact of a vegan diet with exercise on hemorheology - implications for control of diabetic neuropathy. Med Hypotheses 2002; 58: 476-486.
17. Ernst E., Koenig W. Fibrinogen and cardiovascular risk. Vasc Med 1997; 2: 115-125.
18. Ridker P. M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-1818.
19. Pasceri V., Willerson J. T., Yeh E. T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
20. Pasceri V., Chang J., Willerson J. T., Yeh E. T. Modulation of c-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001; 103: 2531-2534.